Ocular Therapeutix
OCUL
#3705
Rank
C$4.75 B
Marketcap
C$22.31
Share price
28.06%
Change (1 day)
68.67%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2025 (TTM): -C$0.36 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are C$55.78 Million. In 2024 the company made an earning of -C$0.27 Billion a decrease over its 2023 earnings that were of -C$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.36 Billion30.79%
2024 -C$0.27 Billion139.68%
2023 -C$0.12 Billion13.65%
2022 -C$98.39 Million984.05%
2021 -C$9.08 Million-95.79%
2020 -C$0.22 Billion80.19%
2019 -C$0.12 Billion44.01%
2018 -C$83.07 Million-5.38%
2017 -C$87.79 Million41.79%
2016 -C$61.92 Million12.47%
2015 -C$55.05 Million38.75%
2014 -C$39.68 Million115.12%
2013 -C$18.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Intersect ENT
XENT
-C$0.23 Billion-35.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
C$18.03 M-105.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.33 B-197.22%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
-C$15.53 Million-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA